Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial - Toyoda, K; Uchiyama, S; Yamaguchi, T; CSPS.com Trial Investigators (Lancet Neurol, 2019)